A clinical evaluation of various tumor markers for the diagnosis of pancreatic cancer
| Autor: | Bunzo Nakata, Tetsuji Sawada, Yong-Suk Chung, Kaoru Umeyama, Hideki Yokomatsu, Katsusuke Satake, Hajime Tanaka, Hideki Nishiwaki |
|---|---|
| Rok vydání: | 1990 |
| Předmět: |
Oncology
medicine.medical_specialty Pathology medicine.medical_treatment Endocrinology Antigen Antigens Neoplasm Pancreatic cancer Internal medicine Biomarkers Tumor medicine Humans Antigens Tumor-Associated Carbohydrate Tumor marker business.industry Gastroenterology medicine.disease Pancreatic Neoplasms Radiation therapy Clinical trial medicine.anatomical_structure CA19-9 business Pancreas Clinical evaluation |
| Zdroj: | International journal of pancreatology. 7:25-36 |
| ISSN: | 2363-5134 0169-4197 |
| DOI: | 10.1007/bf02924217 |
| Popis: | Many substances that are widely used as tumor markers for detecting pancreatic cancer are discussed. Some are good indicators, but some are not. Among them, CA 19-9 and SPan-1 have higher sensitivity and specificity for diagnosis of pancreatic cancer. However, these markers are neither tumor-specific nor pancreatic-cancer-specific. Accurate understanding of the measurement of serum tumor markers makes it possible for them to be useful adjunctive tools for detecting pancreatic cancer, even in small cancers, and for monitoring patients after treatment. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink